nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—Cholestasis—Niacin—atherosclerosis	0.0162	0.0203	CcSEcCtD
Thiabendazole—Numbness—Pravastatin—atherosclerosis	0.0146	0.0183	CcSEcCtD
Thiabendazole—Hepatocellular injury—Ezetimibe—atherosclerosis	0.0141	0.0176	CcSEcCtD
Thiabendazole—Sensory loss—Pravastatin—atherosclerosis	0.014	0.0175	CcSEcCtD
Thiabendazole—Hepatic failure—Rosuvastatin—atherosclerosis	0.0137	0.0171	CcSEcCtD
Thiabendazole—Hepatocellular injury—Simvastatin—atherosclerosis	0.0134	0.0168	CcSEcCtD
Thiabendazole—Hepatocellular injury—Pravastatin—atherosclerosis	0.0121	0.0151	CcSEcCtD
Thiabendazole—Hepatic failure—Lovastatin—atherosclerosis	0.0116	0.0145	CcSEcCtD
Thiabendazole—Hepatic failure—Ezetimibe—atherosclerosis	0.0114	0.0142	CcSEcCtD
Thiabendazole—Hepatic failure—Simvastatin—atherosclerosis	0.0108	0.0135	CcSEcCtD
Thiabendazole—Hepatic failure—Pravastatin—atherosclerosis	0.0098	0.0122	CcSEcCtD
Thiabendazole—Jaundice—Rosuvastatin—atherosclerosis	0.00923	0.0115	CcSEcCtD
Thiabendazole—Haematuria—Rosuvastatin—atherosclerosis	0.00903	0.0113	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00796	0.00993	CcSEcCtD
Thiabendazole—Jaundice—Ezetimibe—atherosclerosis	0.00768	0.00958	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00744	0.00929	CcSEcCtD
Thiabendazole—Jaundice—Simvastatin—atherosclerosis	0.00732	0.00914	CcSEcCtD
Thiabendazole—Erythema multiforme—Lovastatin—atherosclerosis	0.00681	0.00851	CcSEcCtD
Thiabendazole—Angioedema—Rosuvastatin—atherosclerosis	0.00676	0.00844	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00673	0.0084	CcSEcCtD
Thiabendazole—Jaundice—Niacin—atherosclerosis	0.00672	0.00839	CcSEcCtD
Thiabendazole—Flushing—Lovastatin—atherosclerosis	0.00669	0.00835	CcSEcCtD
Thiabendazole—Erythema multiforme—Ezetimibe—atherosclerosis	0.00668	0.00834	CcSEcCtD
Thiabendazole—Jaundice—Pravastatin—atherosclerosis	0.00662	0.00826	CcSEcCtD
Thiabendazole—Flushing—Ezetimibe—atherosclerosis	0.00656	0.00819	CcSEcCtD
Thiabendazole—Chills—Lovastatin—atherosclerosis	0.00647	0.00807	CcSEcCtD
Thiabendazole—Erythema multiforme—Simvastatin—atherosclerosis	0.00637	0.00796	CcSEcCtD
Thiabendazole—Flushing—Simvastatin—atherosclerosis	0.00626	0.00781	CcSEcCtD
Thiabendazole—Hypoaesthesia—Niacin—atherosclerosis	0.00616	0.00769	CcSEcCtD
Thiabendazole—Confusional state—Rosuvastatin—atherosclerosis	0.00609	0.0076	CcSEcCtD
Thiabendazole—Hypoaesthesia—Pravastatin—atherosclerosis	0.00606	0.00757	CcSEcCtD
Thiabendazole—Chills—Simvastatin—atherosclerosis	0.00605	0.00755	CcSEcCtD
Thiabendazole—Visual impairment—Niacin—atherosclerosis	0.00596	0.00745	CcSEcCtD
Thiabendazole—Vision blurred—Lovastatin—atherosclerosis	0.00591	0.00738	CcSEcCtD
Thiabendazole—Visual impairment—Pravastatin—atherosclerosis	0.00587	0.00733	CcSEcCtD
Thiabendazole—Tinnitus—Niacin—atherosclerosis	0.00577	0.0072	CcSEcCtD
Thiabendazole—Erythema multiforme—Pravastatin—atherosclerosis	0.00576	0.00719	CcSEcCtD
Thiabendazole—Flushing—Niacin—atherosclerosis	0.00574	0.00717	CcSEcCtD
Thiabendazole—Angioedema—Lovastatin—atherosclerosis	0.00573	0.00716	CcSEcCtD
Thiabendazole—Tinnitus—Pravastatin—atherosclerosis	0.00568	0.00709	CcSEcCtD
Thiabendazole—Flushing—Pravastatin—atherosclerosis	0.00566	0.00706	CcSEcCtD
Thiabendazole—Angioedema—Ezetimibe—atherosclerosis	0.00562	0.00702	CcSEcCtD
Thiabendazole—Leukopenia—Lovastatin—atherosclerosis	0.00562	0.00701	CcSEcCtD
Thiabendazole—Chills—Niacin—atherosclerosis	0.00555	0.00693	CcSEcCtD
Thiabendazole—Vision blurred—Simvastatin—atherosclerosis	0.00553	0.0069	CcSEcCtD
Thiabendazole—Chills—Pravastatin—atherosclerosis	0.00547	0.00683	CcSEcCtD
Thiabendazole—Angioedema—Simvastatin—atherosclerosis	0.00536	0.00669	CcSEcCtD
Thiabendazole—Dyspepsia—Rosuvastatin—atherosclerosis	0.00532	0.00664	CcSEcCtD
Thiabendazole—Leukopenia—Simvastatin—atherosclerosis	0.00525	0.00656	CcSEcCtD
Thiabendazole—Confusional state—Lovastatin—atherosclerosis	0.00516	0.00644	CcSEcCtD
Thiabendazole—Anaphylactic shock—Lovastatin—atherosclerosis	0.00512	0.00639	CcSEcCtD
Thiabendazole—Vision blurred—Niacin—atherosclerosis	0.00508	0.00634	CcSEcCtD
Thiabendazole—Confusional state—Ezetimibe—atherosclerosis	0.00506	0.00632	CcSEcCtD
Thiabendazole—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00502	0.00627	CcSEcCtD
Thiabendazole—Vision blurred—Pravastatin—atherosclerosis	0.005	0.00624	CcSEcCtD
Thiabendazole—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00498	0.00621	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00494	0.00617	CcSEcCtD
Thiabendazole—Angioedema—Niacin—atherosclerosis	0.00492	0.00615	CcSEcCtD
Thiabendazole—Anorexia—Lovastatin—atherosclerosis	0.00488	0.00609	CcSEcCtD
Thiabendazole—Angioedema—Pravastatin—atherosclerosis	0.00485	0.00605	CcSEcCtD
Thiabendazole—Confusional state—Simvastatin—atherosclerosis	0.00483	0.00603	CcSEcCtD
Thiabendazole—Leukopenia—Niacin—atherosclerosis	0.00482	0.00602	CcSEcCtD
Thiabendazole—Anaphylactic shock—Simvastatin—atherosclerosis	0.00479	0.00598	CcSEcCtD
Thiabendazole—Abdominal pain—Rosuvastatin—atherosclerosis	0.00478	0.00596	CcSEcCtD
Thiabendazole—Leukopenia—Pravastatin—atherosclerosis	0.00475	0.00593	CcSEcCtD
Thiabendazole—Anorexia—Simvastatin—atherosclerosis	0.00457	0.0057	CcSEcCtD
Thiabendazole—Dyspepsia—Lovastatin—atherosclerosis	0.00451	0.00563	CcSEcCtD
Thiabendazole—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00445	0.00556	CcSEcCtD
Thiabendazole—Decreased appetite—Lovastatin—atherosclerosis	0.00445	0.00556	CcSEcCtD
Thiabendazole—Dyspepsia—Ezetimibe—atherosclerosis	0.00442	0.00552	CcSEcCtD
Thiabendazole—Fatigue—Lovastatin—atherosclerosis	0.00441	0.00551	CcSEcCtD
Thiabendazole—Anaphylactic shock—Niacin—atherosclerosis	0.0044	0.00549	CcSEcCtD
Thiabendazole—Confusional state—Pravastatin—atherosclerosis	0.00437	0.00545	CcSEcCtD
Thiabendazole—Decreased appetite—Ezetimibe—atherosclerosis	0.00437	0.00545	CcSEcCtD
Thiabendazole—Asthenia—Rosuvastatin—atherosclerosis	0.00433	0.00541	CcSEcCtD
Thiabendazole—Anaphylactic shock—Pravastatin—atherosclerosis	0.00433	0.0054	CcSEcCtD
Thiabendazole—Fatigue—Ezetimibe—atherosclerosis	0.00433	0.0054	CcSEcCtD
Thiabendazole—Pruritus—Rosuvastatin—atherosclerosis	0.00427	0.00534	CcSEcCtD
Thiabendazole—Feeling abnormal—Lovastatin—atherosclerosis	0.00422	0.00527	CcSEcCtD
Thiabendazole—Dyspepsia—Simvastatin—atherosclerosis	0.00422	0.00526	CcSEcCtD
Thiabendazole—Anorexia—Niacin—atherosclerosis	0.00419	0.00523	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00419	0.00523	CcSEcCtD
Thiabendazole—Decreased appetite—Simvastatin—atherosclerosis	0.00416	0.0052	CcSEcCtD
Thiabendazole—Feeling abnormal—Ezetimibe—atherosclerosis	0.00414	0.00517	CcSEcCtD
Thiabendazole—Diarrhoea—Rosuvastatin—atherosclerosis	0.00413	0.00516	CcSEcCtD
Thiabendazole—Fatigue—Simvastatin—atherosclerosis	0.00413	0.00515	CcSEcCtD
Thiabendazole—Anorexia—Pravastatin—atherosclerosis	0.00413	0.00515	CcSEcCtD
Thiabendazole—Hypotension—Niacin—atherosclerosis	0.00411	0.00513	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00411	0.00513	CcSEcCtD
Thiabendazole—Abdominal pain—Lovastatin—atherosclerosis	0.00405	0.00505	CcSEcCtD
Thiabendazole—Dizziness—Rosuvastatin—atherosclerosis	0.004	0.00499	CcSEcCtD
Thiabendazole—Abdominal pain—Ezetimibe—atherosclerosis	0.00397	0.00496	CcSEcCtD
Thiabendazole—Feeling abnormal—Simvastatin—atherosclerosis	0.00395	0.00493	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00392	0.00489	CcSEcCtD
Thiabendazole—Somnolence—Niacin—atherosclerosis	0.00391	0.00488	CcSEcCtD
Thiabendazole—Dyspepsia—Niacin—atherosclerosis	0.00387	0.00483	CcSEcCtD
Thiabendazole—Decreased appetite—Niacin—atherosclerosis	0.00382	0.00477	CcSEcCtD
Thiabendazole—Dyspepsia—Pravastatin—atherosclerosis	0.00381	0.00476	CcSEcCtD
Thiabendazole—Rash—Rosuvastatin—atherosclerosis	0.00381	0.00476	CcSEcCtD
Thiabendazole—Dermatitis—Rosuvastatin—atherosclerosis	0.00381	0.00475	CcSEcCtD
Thiabendazole—Abdominal pain—Simvastatin—atherosclerosis	0.00379	0.00473	CcSEcCtD
Thiabendazole—Headache—Rosuvastatin—atherosclerosis	0.00378	0.00472	CcSEcCtD
Thiabendazole—Hypersensitivity—Lovastatin—atherosclerosis	0.00377	0.00471	CcSEcCtD
Thiabendazole—Decreased appetite—Pravastatin—atherosclerosis	0.00376	0.0047	CcSEcCtD
Thiabendazole—Fatigue—Pravastatin—atherosclerosis	0.00373	0.00466	CcSEcCtD
Thiabendazole—Hypersensitivity—Ezetimibe—atherosclerosis	0.0037	0.00462	CcSEcCtD
Thiabendazole—Asthenia—Lovastatin—atherosclerosis	0.00367	0.00459	CcSEcCtD
Thiabendazole—Pruritus—Lovastatin—atherosclerosis	0.00362	0.00452	CcSEcCtD
Thiabendazole—Asthenia—Ezetimibe—atherosclerosis	0.0036	0.0045	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Niacin—atherosclerosis	0.0036	0.00449	CcSEcCtD
Thiabendazole—Nausea—Rosuvastatin—atherosclerosis	0.00359	0.00448	CcSEcCtD
Thiabendazole—Feeling abnormal—Pravastatin—atherosclerosis	0.00357	0.00445	CcSEcCtD
Thiabendazole—Pruritus—Ezetimibe—atherosclerosis	0.00355	0.00444	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00354	0.00442	CcSEcCtD
Thiabendazole—Hypersensitivity—Simvastatin—atherosclerosis	0.00353	0.0044	CcSEcCtD
Thiabendazole—Diarrhoea—Lovastatin—atherosclerosis	0.0035	0.00437	CcSEcCtD
Thiabendazole—Abdominal pain—Niacin—atherosclerosis	0.00348	0.00434	CcSEcCtD
Thiabendazole—Asthenia—Simvastatin—atherosclerosis	0.00344	0.00429	CcSEcCtD
Thiabendazole—Diarrhoea—Ezetimibe—atherosclerosis	0.00344	0.00429	CcSEcCtD
Thiabendazole—Abdominal pain—Pravastatin—atherosclerosis	0.00342	0.00427	CcSEcCtD
Thiabendazole—Pruritus—Simvastatin—atherosclerosis	0.00339	0.00423	CcSEcCtD
Thiabendazole—Dizziness—Lovastatin—atherosclerosis	0.00339	0.00423	CcSEcCtD
Thiabendazole—Dizziness—Ezetimibe—atherosclerosis	0.00332	0.00415	CcSEcCtD
Thiabendazole—Diarrhoea—Simvastatin—atherosclerosis	0.00328	0.00409	CcSEcCtD
Thiabendazole—Vomiting—Lovastatin—atherosclerosis	0.00326	0.00406	CcSEcCtD
Thiabendazole—Hypersensitivity—Niacin—atherosclerosis	0.00324	0.00404	CcSEcCtD
Thiabendazole—Rash—Lovastatin—atherosclerosis	0.00323	0.00403	CcSEcCtD
Thiabendazole—Dermatitis—Lovastatin—atherosclerosis	0.00323	0.00403	CcSEcCtD
Thiabendazole—Headache—Lovastatin—atherosclerosis	0.00321	0.004	CcSEcCtD
Thiabendazole—Vomiting—Ezetimibe—atherosclerosis	0.00319	0.00399	CcSEcCtD
Thiabendazole—Hypersensitivity—Pravastatin—atherosclerosis	0.00319	0.00398	CcSEcCtD
Thiabendazole—Dizziness—Simvastatin—atherosclerosis	0.00317	0.00395	CcSEcCtD
Thiabendazole—Rash—Ezetimibe—atherosclerosis	0.00317	0.00395	CcSEcCtD
Thiabendazole—Dermatitis—Ezetimibe—atherosclerosis	0.00316	0.00395	CcSEcCtD
Thiabendazole—Asthenia—Niacin—atherosclerosis	0.00316	0.00394	CcSEcCtD
Thiabendazole—Headache—Ezetimibe—atherosclerosis	0.00315	0.00393	CcSEcCtD
Thiabendazole—Pruritus—Niacin—atherosclerosis	0.00311	0.00388	CcSEcCtD
Thiabendazole—Asthenia—Pravastatin—atherosclerosis	0.00311	0.00388	CcSEcCtD
Thiabendazole—Pruritus—Pravastatin—atherosclerosis	0.00306	0.00382	CcSEcCtD
Thiabendazole—Vomiting—Simvastatin—atherosclerosis	0.00304	0.0038	CcSEcCtD
Thiabendazole—Nausea—Lovastatin—atherosclerosis	0.00304	0.0038	CcSEcCtD
Thiabendazole—Rash—Simvastatin—atherosclerosis	0.00302	0.00377	CcSEcCtD
Thiabendazole—Dermatitis—Simvastatin—atherosclerosis	0.00302	0.00377	CcSEcCtD
Thiabendazole—Diarrhoea—Niacin—atherosclerosis	0.00301	0.00376	CcSEcCtD
Thiabendazole—Headache—Simvastatin—atherosclerosis	0.003	0.00375	CcSEcCtD
Thiabendazole—Nausea—Ezetimibe—atherosclerosis	0.00298	0.00372	CcSEcCtD
Thiabendazole—Diarrhoea—Pravastatin—atherosclerosis	0.00296	0.0037	CcSEcCtD
Thiabendazole—Dizziness—Niacin—atherosclerosis	0.00291	0.00363	CcSEcCtD
Thiabendazole—Dizziness—Pravastatin—atherosclerosis	0.00286	0.00357	CcSEcCtD
Thiabendazole—Nausea—Simvastatin—atherosclerosis	0.00284	0.00355	CcSEcCtD
Thiabendazole—Vomiting—Niacin—atherosclerosis	0.0028	0.00349	CcSEcCtD
Thiabendazole—Rash—Niacin—atherosclerosis	0.00277	0.00346	CcSEcCtD
Thiabendazole—Dermatitis—Niacin—atherosclerosis	0.00277	0.00346	CcSEcCtD
Thiabendazole—Headache—Niacin—atherosclerosis	0.00275	0.00344	CcSEcCtD
Thiabendazole—Vomiting—Pravastatin—atherosclerosis	0.00275	0.00344	CcSEcCtD
Thiabendazole—Rash—Pravastatin—atherosclerosis	0.00273	0.00341	CcSEcCtD
Thiabendazole—Dermatitis—Pravastatin—atherosclerosis	0.00273	0.0034	CcSEcCtD
Thiabendazole—Headache—Pravastatin—atherosclerosis	0.00271	0.00339	CcSEcCtD
Thiabendazole—Nausea—Niacin—atherosclerosis	0.00261	0.00326	CcSEcCtD
Thiabendazole—Nausea—Pravastatin—atherosclerosis	0.00257	0.00321	CcSEcCtD
Thiabendazole—CYP1A1—PPARA activates gene expression—APOA2—atherosclerosis	0.00149	0.00752	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA2—atherosclerosis	0.00146	0.00736	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.00144	0.00722	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.00143	0.0072	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—LPL—atherosclerosis	0.00139	0.00698	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—APOA5—atherosclerosis	0.00137	0.00687	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA5—atherosclerosis	0.00134	0.00673	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.00132	0.00666	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—EDN1—atherosclerosis	0.00132	0.00664	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—CD36—atherosclerosis	0.00132	0.00663	CbGpPWpGaD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—GPX1—atherosclerosis	0.00127	0.00637	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP7A1—atherosclerosis	0.00119	0.006	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP7A1—atherosclerosis	0.00118	0.00592	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CYP7A1—atherosclerosis	0.00115	0.00578	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—atherosclerosis	0.00111	0.00559	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP27A1—atherosclerosis	0.0011	0.00554	CbGpPWpGaD
Thiabendazole—CYP1A2—Estrogen Receptor Pathway—STAT3—atherosclerosis	0.00109	0.00548	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP27A1—atherosclerosis	0.00109	0.00547	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—APOE—atherosclerosis	0.00107	0.0054	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA2—atherosclerosis	0.00101	0.00507	CbGpPWpGaD
Thiabendazole—CYP1A1—Melatonin metabolism and effects—NFKB1—atherosclerosis	0.001	0.00503	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000996	0.00501	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—HMGCR—atherosclerosis	0.000988	0.00497	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—NFKB1—atherosclerosis	0.000974	0.0049	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—HMGCR—atherosclerosis	0.000967	0.00486	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA5—atherosclerosis	0.000922	0.00464	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—LPL—atherosclerosis	0.000885	0.00445	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—ABCA1—atherosclerosis	0.000881	0.00443	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—atherosclerosis	0.000862	0.00434	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—CD36—atherosclerosis	0.000841	0.00423	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—atherosclerosis	0.000832	0.00418	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000823	0.00414	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—GPX1—atherosclerosis	0.000808	0.00406	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—atherosclerosis	0.000798	0.00401	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000784	0.00394	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP7A1—atherosclerosis	0.000761	0.00382	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP7A1—atherosclerosis	0.00075	0.00377	CbGpPWpGaD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—PTGS2—atherosclerosis	0.000746	0.00375	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—atherosclerosis	0.000742	0.00373	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000737	0.00371	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—atherosclerosis	0.000709	0.00356	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP27A1—atherosclerosis	0.000703	0.00354	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000693	0.00349	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	0.000692	0.00348	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—HMGCR—atherosclerosis	0.000667	0.00335	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—CD36—atherosclerosis	0.000657	0.0033	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—atherosclerosis	0.000643	0.00323	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000639	0.00321	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000639	0.00321	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—NFKB1—atherosclerosis	0.000638	0.00321	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	0.000628	0.00316	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—PPARA—atherosclerosis	0.000611	0.00307	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atherosclerosis	0.000598	0.003	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—atherosclerosis	0.000594	0.00299	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—AGT—atherosclerosis	0.000591	0.00297	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—atherosclerosis	0.000579	0.00291	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	0.000577	0.0029	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—APOA1—atherosclerosis	0.000573	0.00288	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA1—atherosclerosis	0.000561	0.00282	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	0.000538	0.00271	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	0.000538	0.00271	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—GSTM1—atherosclerosis	0.000537	0.0027	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atherosclerosis	0.00053	0.00267	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—atherosclerosis	0.000509	0.00256	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000505	0.00254	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—PPARG—atherosclerosis	0.000505	0.00254	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.0005	0.00251	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—atherosclerosis	0.000494	0.00248	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—GSTM1—atherosclerosis	0.000493	0.00248	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—GSTM1—atherosclerosis	0.000486	0.00244	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—PTGS2—atherosclerosis	0.000476	0.00239	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000475	0.00239	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000475	0.00239	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atherosclerosis	0.000473	0.00238	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.00047	0.00236	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000466	0.00234	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000458	0.0023	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—atherosclerosis	0.000443	0.00223	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	0.000441	0.00222	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000423	0.00213	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atherosclerosis	0.000412	0.00207	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000408	0.00205	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000408	0.00205	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000401	0.00202	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000401	0.00202	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000401	0.00202	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000401	0.00202	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	0.000401	0.00201	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—atherosclerosis	0.000399	0.00201	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000397	0.00199	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—atherosclerosis	0.000386	0.00194	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000383	0.00193	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	0.000368	0.00185	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000367	0.00185	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000353	0.00178	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LDLRAP1—atherosclerosis	0.000349	0.00176	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	0.000343	0.00173	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	0.000343	0.00173	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000341	0.00172	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—atherosclerosis	0.00034	0.00171	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PLTP—atherosclerosis	0.000328	0.00165	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000322	0.00162	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTM1—atherosclerosis	0.000314	0.00158	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTM1—atherosclerosis	0.00031	0.00156	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000304	0.00153	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000303	0.00152	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000303	0.00152	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000302	0.00152	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.0003	0.00151	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000297	0.00149	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000294	0.00148	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000292	0.00147	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCG8—atherosclerosis	0.000285	0.00143	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LTA4H—atherosclerosis	0.000285	0.00143	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000281	0.00141	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.00027	0.00136	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000265	0.00133	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000256	0.00129	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000256	0.00129	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000256	0.00129	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000256	0.00129	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000253	0.00127	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000244	0.00123	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000237	0.00119	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000234	0.00118	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000225	0.00113	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCG1—atherosclerosis	0.000225	0.00113	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	0.000223	0.00112	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000218	0.00109	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LCAT—atherosclerosis	0.000212	0.00106	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—FABP4—atherosclerosis	0.000212	0.00106	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PLTP—atherosclerosis	0.000209	0.00105	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—APOA4—atherosclerosis	0.000208	0.00104	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP7A1—atherosclerosis	0.000204	0.00103	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000194	0.000978	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000194	0.000975	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000193	0.000969	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000192	0.000963	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP27A1—atherosclerosis	0.000189	0.000948	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000187	0.000941	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000186	0.000933	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCG8—atherosclerosis	0.000182	0.000913	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LTA4H—atherosclerosis	0.000182	0.000913	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000181	0.000911	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000179	0.000901	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALOX15—atherosclerosis	0.000179	0.000899	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—APOA2—atherosclerosis	0.000179	0.000899	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALOX5AP—atherosclerosis	0.000179	0.000899	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PLA2G2A—atherosclerosis	0.000179	0.000899	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCG5—atherosclerosis	0.000177	0.000888	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000176	0.000887	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LPA—atherosclerosis	0.000171	0.000857	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000169	0.000851	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—BGN—atherosclerosis	0.000165	0.00083	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000164	0.000825	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—APOA5—atherosclerosis	0.000164	0.000822	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000159	0.000799	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PLA2G1B—atherosclerosis	0.000157	0.000791	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000156	0.000782	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000154	0.000775	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000154	0.000773	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALOX5—atherosclerosis	0.000152	0.000764	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000151	0.000758	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCG1—atherosclerosis	0.000143	0.000721	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.00014	0.000706	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NAMPT—atherosclerosis	0.000136	0.000685	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000136	0.000681	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LIPC—atherosclerosis	0.000135	0.000681	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LCAT—atherosclerosis	0.000135	0.000678	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—FABP4—atherosclerosis	0.000135	0.000678	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—APOC3—atherosclerosis	0.000135	0.000677	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LDLR—atherosclerosis	0.000134	0.000673	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—APOA4—atherosclerosis	0.000132	0.000666	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CETP—atherosclerosis	0.000131	0.000657	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP7A1—atherosclerosis	0.00013	0.000654	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SCARB1—atherosclerosis	0.000125	0.000629	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000124	0.000623	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000122	0.000613	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP27A1—atherosclerosis	0.00012	0.000605	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000118	0.000595	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HMGCR—atherosclerosis	0.000118	0.000594	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000115	0.000581	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—APOA2—atherosclerosis	0.000114	0.000573	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	0.000114	0.000573	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALOX15—atherosclerosis	0.000114	0.000573	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	0.000114	0.000573	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCG5—atherosclerosis	0.000113	0.000566	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000112	0.000565	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LPA—atherosclerosis	0.000109	0.000547	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000107	0.000536	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCA1—atherosclerosis	0.000105	0.00053	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—BGN—atherosclerosis	0.000105	0.00053	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000105	0.000526	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—APOA5—atherosclerosis	0.000104	0.000524	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000101	0.000509	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	0.0001	0.000505	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	9.92e-05	0.000499	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	9.83e-05	0.000494	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	9.81e-05	0.000493	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALOX5—atherosclerosis	9.69e-05	0.000487	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HMOX1—atherosclerosis	9.04e-05	0.000455	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.95e-05	0.00045	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NAMPT—atherosclerosis	8.69e-05	0.000437	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—APOB—atherosclerosis	8.66e-05	0.000435	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.64e-05	0.000435	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LIPC—atherosclerosis	8.64e-05	0.000434	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—APOC3—atherosclerosis	8.59e-05	0.000432	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LDLR—atherosclerosis	8.53e-05	0.000429	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTM1—atherosclerosis	8.42e-05	0.000424	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CETP—atherosclerosis	8.33e-05	0.000419	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LPL—atherosclerosis	8.27e-05	0.000416	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GPX1—atherosclerosis	8.07e-05	0.000406	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SCARB1—atherosclerosis	7.98e-05	0.000401	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CD36—atherosclerosis	7.86e-05	0.000395	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.77e-05	0.000391	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HMGCR—atherosclerosis	7.54e-05	0.000379	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MTHFR—atherosclerosis	7.44e-05	0.000374	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPARA—atherosclerosis	7.3e-05	0.000367	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AGT—atherosclerosis	7.07e-05	0.000356	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—APOE—atherosclerosis	6.93e-05	0.000348	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CAV1—atherosclerosis	6.87e-05	0.000345	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—APOA1—atherosclerosis	6.85e-05	0.000344	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.8e-05	0.000342	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCA1—atherosclerosis	6.72e-05	0.000338	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CG—atherosclerosis	6.25e-05	0.000314	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPARG—atherosclerosis	6.04e-05	0.000304	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—INS—atherosclerosis	5.92e-05	0.000298	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HMOX1—atherosclerosis	5.76e-05	0.00029	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—APOB—atherosclerosis	5.52e-05	0.000278	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALB—atherosclerosis	5.43e-05	0.000273	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTM1—atherosclerosis	5.37e-05	0.00027	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LPL—atherosclerosis	5.27e-05	0.000265	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NOS3—atherosclerosis	5.19e-05	0.000261	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GPX1—atherosclerosis	5.14e-05	0.000259	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CD36—atherosclerosis	5.01e-05	0.000252	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTGS2—atherosclerosis	4.75e-05	0.000239	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MTHFR—atherosclerosis	4.75e-05	0.000239	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPARA—atherosclerosis	4.66e-05	0.000234	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AGT—atherosclerosis	4.51e-05	0.000227	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—APOE—atherosclerosis	4.42e-05	0.000222	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CAV1—atherosclerosis	4.38e-05	0.00022	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—APOA1—atherosclerosis	4.37e-05	0.00022	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CG—atherosclerosis	3.99e-05	0.000201	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPARG—atherosclerosis	3.85e-05	0.000194	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—INS—atherosclerosis	3.78e-05	0.00019	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALB—atherosclerosis	3.46e-05	0.000174	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NOS3—atherosclerosis	3.31e-05	0.000166	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.03e-05	0.000152	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AKT1—atherosclerosis	2.39e-05	0.00012	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AKT1—atherosclerosis	1.52e-05	7.65e-05	CbGpPWpGaD
